V029-6212 Screening compound: 1-{2-[(3,4-difluorophenyl)(phenyl)methoxy]ethyl}-4-{[5-(pyridin-2-yl)thiophen-2-yl]sulfonyl}piperazine

V029-6212 Screening compound: 1-{2-[(3,4-difluorophenyl)(phenyl)methoxy]ethyl}-4-{[5-(pyridin-2-yl)thiophen-2-yl]sulfonyl}piperazine
V029-6212 Screening compound: 1-{2-[(3,4-difluorophenyl)(phenyl)methoxy]ethyl}-4-{[5-(pyridin-2-yl)thiophen-2-yl]sulfonyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-6212
1-{2-[(3,4-difluorophenyl)(phenyl)methoxy]ethyl}-4-{[5-(pyridin-2-yl)thiophen-2-yl]sulfonyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-6212

Molecular Formula

C28H27F2N3O3S2 (C28 H27 F2 N3 O3 S2)

Compound Name

1-{2-[(3,4-difluorophenyl)(phenyl)methoxy]ethyl}-4-{[5-(pyridin-2-yl)thiophen-2-yl]sulfonyl}piperazine

IUPAC name

1-{2-[(34-difluorophenyl)(phenyl)methoxy]ethyl}-4-{[5-(pyridin-2-yl)thiophen-2-yl]sulfonyl}piperazine

SMILES

O=S(c1ccc(-c2ncccc2)s1)(N1CCN(CCOC(c2ccccc2)c(cc2)cc(F)c2F)CC1)=O

InChI

InChI=1S/C28H27F2N3O3S2/c29-23-10-9-22(20-24(23)30)28(21-6-2-1-3-7-21)36-19-18-32-14-16-33(17-15-32)38(34,35)27-12-11-26(37-27)25-8-4-5-13-31-25/h1-13,20,28H,14-19H2/t28-/m0/s1

InChI Key

VRISNCKSJDUUME-NDEPHWFRSA-N

MDL Number (MFCD)

MFCD19965126

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

555.67

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.424

Distribution Coefficient, logD

5.414

Water Solubility, LogSw

-5.82

Polar Surface Area

52.165

Acid Dissociation Constant (pKa)

22.84

Base Dissociation Constant (pKb)

5.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.00

V029-6212 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

DGK Inhibitors Library (10558 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
Targets:
  • Kinases
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V029-6212 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-6212?
Check Price and Availability of V029-6212, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-6212 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-6212
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-6212
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-6212 available by request